Nebulized ensifentrine, when added to tiotropium, produced clinically meaningful and significant improvements in lung function and quality of life in patients with COPD.
Exhalation delivery system with fluticasone provided significant reduction in nasal congestion and polyp grade in patients with nasal polyps with moderate or severe congestion on conventional intranasal steroids.
GABA agonists for chronic pain, such as gabapentin and pregabalin, were not associated with higher prevalence of allergic rhinoconjunctivitis and asthma.
Dupilumab significantly reduced severe asthma exacerbations in patients with oral corticosteroid-dependent severe asthma with and without early improvements in lung function.
Obesity and age do not appear to influence the survival of patients with NSCLC treated with programmed death receptor-1 (PD-1)/programmed cell death ligand 1 (PD-L1) immune checkpoint inhibitors.
